We performed bioinformatic analysis of somatic mutations combined with TMB and clinical prognosis in the present study, identifying HMCN1 (Hemicentin 1) mutation as a critical event in ccRCC progression. The gene discussed is HMCN1; the disease is nonpapillary renal cell carcinoma.